Getinge AB (CHIX:GETIBS) Long-Term Debt: kr7,942 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GETIBS Getinge AB CHIX:GETIBS
73 GF Score
Price kr231.00
GF Value kr192.70
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Getinge AB Long-Term Debt?

Getinge AB CHIX:GETIBS 73 Long-Term Debt is kr7,942 Mil as of Jun. 2026. GuruFocus rates CHIX:GETIBS with a GF Score™ of 73/100 and a GF Value™ of kr192.70 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Getinge AB's Long-Term Debt for the quarter that ended in Jun. 2026 was kr7,942 Mil.

Getinge AB's quarterly Long-Term Debt increased from Dec. 2025 (kr7,893 Mil) to Mar. 2026 (kr7,953 Mil) but then declined from Mar. 2026 (kr7,953 Mil) to Jun. 2026 (kr7,942 Mil).

Getinge AB's annual Long-Term Debt increased from Dec. 2023 (kr3,903 Mil) to Dec. 2024 (kr6,971 Mil) and increased from Dec. 2024 (kr6,971 Mil) to Dec. 2025 (kr7,893 Mil).

Getinge AB  (CHIX:GETIBs) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Getinge AB Long-Term Debt Related Terms

Getinge AB Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Getinge AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB Long-Term Debt Chart

Getinge AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,795.00 4,100.00 3,903.00 6,971.00 7,893.00

Getinge AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,910.00 8,545.00 7,893.00 7,953.00 7,942.00
CHIX:GETIBS
73GF Score
Getinge AB CHIX:GETIBS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of kr7,942 Mil mean?
Getinge AB (CHIX:GETIBS) has a Long-Term Debt of kr7,942 Mil as of Jun. 2026.
Is Getinge AB's Long-Term Debt too high?
Getinge AB's current Long-Term Debt is kr7,942 Mil. Overall, Getinge AB has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Long-Term Debt compare to ABT and SYK?
Getinge AB's Long-Term Debt of kr7,942 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Getinge AB's current Long-Term Debt is kr7,942 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (CHIX:GETIBS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr192.70, compared to a current price of kr231.00 — trading 19.9% above its estimated fair value. The current Long-Term Debt is kr7,942 Mil. Getinge AB's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Getinge AB (CHIX:GETIBS), the current Long-Term Debt is kr7,942 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Getinge AB (CHIX:GETIBS) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued. The current stock price of kr231.00 is trading 19.9% above its estimated GF Value™ of kr192.70. GuruFocus considers Getinge AB to be Modestly Overvalued.

Key valuation signals for CHIX:GETIBS:

  • Long-Term Debt: kr7,942 Mil
  • GF Value™: kr192.70 vs. price of kr231.00 (19.9% above fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the CHIX:GETIBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
73GF Score

Get the complete analysis for CHIX:GETIBS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr231.00
Price
kr192.70
GF Value